Skip to content
TrialScanner

NCT04854746

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine

Phase 1CompletedVXRTLead

Registry record

Lead sponsor
Vaxart
Conditions
Norovirus Infections
Primary completion
Jan 4, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04854746 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04854746: Ph 1b: Safety & Immunogenicit... | TrialScanner